Related Experiment Video
Updated: Jun 25, 2026

05:29
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
MSH6 inactivation and emergent temozolomide resistance in human glioblastomas
Daniel P Cahill1, Patrick J Codd, Tracy T Batchelor
1Neurosurgical Service, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Abstract
No abstract available in PubMed .

